Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400095027Phase 4Recruiting
Phase 4 trial of esmolol in rhinosinusitis and nasal polyp (2 arms), sponsored by Tengzhou Central People's Hospital. Primary endpoints: Blood pressure and heart rate values, Blood glucose levels and 2 more. Started Dec 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400095027.